Trinity Biotech PLC ADR | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
22,317.10
8,827.70
101,953.40
77,535.00
57,607.00
30,277
Total Accounts Receivable
21,649.10
20,827.90
20,656.10
20,267.40
19,181.00
25,218
Inventories
29,670.20
32,506.10
35,125.20
32,769.00
32,805.00
30,359
Other Current Assets
3,106.00
4,705.80
5,496.00
3,654.10
2,998.00
807
Total Current Assets
76,742.50
66,867.50
163,230.70
134,225.50
112,591.00
86,661
Net Property, Plant & Equipment
12,991.10
17,338.30
20,659.10
13,477.00
5,800.00
5,362
Total Investments and Advances
-
-
4,690.00
-
360.00
-
Long-Term Note Receivable
1,084.00
1,082.40
874.00
792.40
685.00
476
Intangible Assets
128,547.80
140,654.00
161,358.70
87,757.20
64,754.00
52,951
Other Assets
78.00
75.70
80.00
82.50
86.00
82
Total Assets
226,487.30
235,520.60
363,684.60
250,971.00
192,974.00
151,659
ST Debt & Current Portion LT Debt
-
-
271.00
274.50
354.00
Accounts Payable
8,154.00
9,184.60
8,329.00
9,066.80
8,045.00
Income Tax Payable
770.00
761.30
1,163.00
176.00
310.00
Other Current Liabilities
12,052.10
11,446.40
10,382.00
15,902.40
12,520.00
Total Current Liabilities
20,976.10
21,392.40
20,145.10
25,419.70
21,229.00
Long-Term Debt
-
-
92,556.40
93,477.60
93,487.00
Deferred Taxes
10,859.10
11,290.20
12,027.10
3,826.00
2,134.00
Other Liabilities
4,596.00
2,298.60
12,271.10
4,283.50
2,230.00
Total Liabilities
43,475.30
44,483.90
149,791.60
141,643.30
127,778.00
Common Equity (Total)
183,012.10
191,036.70
213,892.90
109,327.70
65,196.00
Total Shareholders' Equity
183,012.10
191,036.70
213,892.90
109,327.70
65,196.00
Total Equity
183,012.10
191,036.70
213,892.90
109,327.70
65,196.00
Liabilities & Shareholders' Equity
226,487.30
235,520.60
363,684.60
250,971.00
192,974.00

About Trinity Biotech

View Profile
Address
IDA Business Park
Bray Wicklow 10
Ireland
Employees -
Website http://www.trinitybiotech.com
Updated 07/08/2019
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segment. The company was founded by Ronan O'Caoimh and Denis R.